News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
336,461 Results
Type
Article (16124)
Company Profile (309)
Press Release (320022)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (93680)
Career Advice (289)
Deals (18770)
Drug Delivery (39)
Drug Development (55828)
Employer Resources (35)
FDA (7058)
Job Trends (6425)
News (171805)
Policy (12807)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (982)
Accelerated approval (21)
Adcomms (14)
Allergies (83)
Alliances (25623)
ALS (142)
Alzheimer's disease (1102)
Antibody-drug conjugate (ADC) (245)
Approvals (7278)
Artificial intelligence (272)
Autoimmune disease (117)
Automation (11)
Bankruptcy (167)
Best Places to Work (5655)
BIOSECURE Act (6)
Biosimilars (116)
Biotechnology (237)
Bladder cancer (105)
Brain cancer (50)
Breast cancer (360)
Cancer (3378)
Cardiovascular disease (252)
Career advice (255)
Career pathing (7)
CAR-T (239)
CDC (5)
Celiac Disease (1)
Cell therapy (606)
Cervical cancer (16)
Clinical research (48287)
Collaboration (1201)
Company closure (2)
Compensation (616)
Complete response letters (44)
COVID-19 (1152)
CRISPR (86)
C-suite (583)
Cystic fibrosis (122)
Data (4622)
Denatured (15)
Depression (96)
Diabetes (273)
Diagnostics (1985)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (196)
Drug pricing (58)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (36908)
Editorial (26)
Employer branding (5)
Employer resources (33)
Events (59044)
Executive appointments (683)
FDA (9048)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1059)
Gene editing (186)
Generative AI (21)
Gene therapy (505)
GLP-1 (527)
Government (1394)
Grass and pollen (3)
Guidances (198)
Healthcare (7992)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (195)
Immuno-oncology (42)
Indications (70)
Infectious disease (1266)
Inflammatory bowel disease (161)
Inflation Reduction Act (12)
Influenza (42)
Intellectual property (179)
Interviews (40)
IPO (10313)
IRA (17)
Job creations (1058)
Job search strategy (220)
JPM (41)
Kidney cancer (9)
Labor market (22)
Layoffs (255)
Leadership (9)
Legal (2190)
Liver cancer (54)
Longevity (11)
Lung cancer (448)
Lymphoma (285)
Machine learning (27)
Management (9)
Manufacturing (401)
MASH (137)
Medical device (4129)
Medtech (4142)
Mergers & acquisitions (9290)
Metabolic disorders (768)
Multiple sclerosis (112)
NASH (13)
Neurodegenerative disease (245)
Neuropsychiatric disorders (70)
Neuroscience (2076)
Neurotech (1)
NextGen: Class of 2026 (2802)
Non-profit (1034)
Now hiring (30)
Obesity (345)
Opinion (131)
Ovarian cancer (135)
Pain (119)
Pancreatic cancer (181)
Parkinson's disease (239)
Partnered (15)
Patents (332)
Patient recruitment (353)
Peanut (45)
People (30499)
Pharmaceutical (44)
Pharmacy benefit managers (8)
Phase 1 (16725)
Phase 2 (22432)
Phase 3 (14498)
Pipeline (3550)
Policy (99)
Postmarket research (952)
Preclinical (6853)
Press Release (31)
Prostate cancer (156)
Psychedelics (51)
Radiopharmaceuticals (247)
Rare diseases (702)
Real estate (1905)
Recruiting (13)
Regulatory (11897)
Reports (23)
Research institute (1079)
Resumes & cover letters (32)
Rett syndrome (26)
RNA editing (21)
RSV (22)
Schizophrenia (127)
Series A (190)
Series B (145)
Service/supplier (1)
Sickle cell disease (82)
Special edition (18)
Spinal muscular atrophy (129)
Sponsored (16)
Startups (2271)
State (2)
Stomach cancer (7)
Supply chain (42)
Tariffs (19)
The Weekly (62)
Vaccines (359)
Venture capital (69)
Weight loss (178)
Women's health (27)
Worklife (2)
Date
Today (28)
Last 7 days (366)
Last 30 days (1470)
Last 365 days (19795)
2026 (1793)
2025 (20104)
2024 (23016)
2023 (25448)
2022 (30968)
2021 (32544)
2020 (28222)
2019 (20268)
2018 (14971)
2017 (16761)
2016 (14430)
2015 (17803)
2014 (12796)
2013 (9516)
2012 (9686)
2011 (9526)
2010 (9127)
Location
Africa (169)
Alabama (66)
Alaska (2)
Arizona (111)
Arkansas (5)
Asia (21082)
Australia (3436)
California (7694)
Canada (1945)
China (821)
Colorado (264)
Connecticut (284)
Delaware (246)
Europe (44447)
Florida (1059)
Georgia (233)
Hawaii (2)
Idaho (24)
Illinois (454)
India (35)
Indiana (222)
Iowa (8)
Japan (240)
Kansas (85)
Kentucky (16)
Louisiana (9)
Maine (56)
Maryland (834)
Massachusetts (6011)
Michigan (174)
Minnesota (277)
Mississippi (6)
Missouri (49)
Montana (17)
Nebraska (8)
Nevada (67)
New Hampshire (30)
New Jersey (1898)
New Mexico (14)
New York (1964)
North Carolina (986)
North Dakota (6)
Northern California (3731)
Ohio (199)
Oklahoma (11)
Oregon (26)
Pennsylvania (1428)
Puerto Rico (9)
Rhode Island (26)
South America (269)
South Carolina (16)
Southern California (3077)
Tennessee (72)
Texas (1110)
United States (26174)
Utah (136)
Vermont (1)
Virginia (175)
Washington D.C. (39)
Washington State (630)
West Virginia (2)
Wisconsin (52)
336,461 Results for "orphan therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy
January 19, 2026
·
5 min read
Press Releases
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
December 18, 2025
·
3 min read
Press Releases
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
January 20, 2026
·
7 min read
Press Releases
Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis
January 20, 2026
·
4 min read
Drug pricing
CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiations
Expanded exemptions for orphan drugs could mean prolonged protections for top-selling drugs like Merck’s Keytruda, which was initially approved under this designation in 2014.
October 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma
February 5, 2026
·
10 min read
Press Releases
Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis
December 10, 2025
·
3 min read
Press Releases
Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program
December 4, 2025
·
6 min read
Press Releases
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
October 30, 2025
·
3 min read
Press Releases
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
January 22, 2026
·
4 min read
1 of 33,647
Next
